+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bovine Respiratory Disease Treatment Market by Product Type (Antibiotics, Vaccines), Route Of Administration (Injectable, Intranasal, Oral), Animal Type, Distribution Channel - Global Forecast 2025-2030- Product Image
Bovine Respiratory Disease Treatment Market by Product Type (Antibiotics, Vaccines), Route Of Administration (Injectable, Intranasal, Oral), Animal Type, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Bovine Respiratory Disease Treatment Market by Product Type (Antibiotics, Vaccines), Route Of Administration (Injectable, Intranasal, Oral), Animal Type, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011091
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bovine respiratory disease treatment market is evolving rapidly, with industry leaders seeking new strategies amid changing regulatory demands and the emergence of innovative therapies. As antibiotic stewardship gains prominence and value chains adapt, executives need actionable insight to safeguard operations and drive sustainable growth in a shifting animal health landscape.

Market Snapshot: Bovine Respiratory Disease Treatment Market

The bovine respiratory disease treatment market grew from USD 2.10 billion in 2024 to USD 2.27 billion in 2025. It is projected to continue expanding at a CAGR of 7.61% to reach USD 3.27 billion by 2030. This growth is driven by the persistent prevalence of the BRD complex among cattle populations, advancements in therapeutic innovation, and evolving operational models among global beef and dairy producers. Shifting market expectations and regulatory frameworks are prompting companies to realign their R&D strategies, distribution networks, and product portfolios, reflecting the industry's focus on effective, sustainable disease control.

Scope & Segmentation of the Bovine Respiratory Disease Treatment Market

  • Product Types: Includes antibiotics (beta lactams, fluoroquinolones, macrolides—tilmicosin, tulathromycin, tylosin—and tetracyclines) and vaccines (inactivated formulations such as BRSV, Pasteurella, PI3, plus live attenuated options like BRSV, Mannheimia, PI3).
  • Routes of Administration: Covers injectable (intramuscular, intravenous, subcutaneous), intranasal, and oral methods (via feed or water).
  • Animal Categories: Segmentation reflects adult cattle (beef cattle, dairy cows), calves (beef and dairy), and heifers, highlighting variations in disease management requirements.
  • Distribution Channels: Distribution occurs across feed mills (commercial, on-farm), online pharmacies (animal health platforms, general e-retail), and veterinary clinics (independent clinics, large practices).
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), EMEA (including the UK, Germany, France, Russia, UAE, Saudi Arabia, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea and additional key markets).
  • Key Technologies: Novel biologics, improved vaccine delivery systems, real-time digital monitoring, and data-driven herd health management platforms.

Key Takeaways for Senior Decision-Makers

  • Integrated antimicrobial stewardship and precision therapeutics are influencing both product development and industry collaboration, as regulatory bodies require reduced antibiotic use and increased surveillance.
  • Emerging digital health platforms are transforming early detection and intervention, enabling faster, more accurate responses to disease outbreaks within herds.
  • Regional diversity in veterinary infrastructure, regulatory enforcement, and supply chain maturity necessitates distinct go-to-market and operational strategies in each target geography.
  • Manufacturers responding proactively to new guidelines and customer expectations are expanding portfolios through R&D collaborations, strategic acquisitions, and deployment of advanced delivery systems.
  • Market segmentation across product types, routes, and distribution channels supports tailored innovation, optimizing outcomes for specific user groups and markets.

Tariff Impact: Navigating U.S. Tariff Disruptions

The introduction of revised U.S. tariffs in 2025 is reshaping the supply chain for active pharmaceutical ingredients. Increased import duties are leading to higher raw material costs and prompting a shift toward domestic manufacturing partnerships and sourcing diversification. Companies are reevaluating inventory management and distribution to address longer lead times and increased production complexity, emphasizing supply chain resilience for uninterrupted product availability.

Methodology & Data Sources

This research integrates comprehensive desk research, detailed interviews with industry stakeholders, and robust data triangulation. Peer-reviewed literature, regulatory filings, patent mapping, and direct input from veterinarians, herd managers, developers, and supply chain experts inform qualitative and quantitative insights, ensuring each strategic recommendation is grounded in validated, current data.

Bovine Respiratory Disease Treatment Market: Why This Report Matters

  • Empowers leaders to align innovation portfolios with shifting regulatory and market demands, supporting long-term competitive positioning in a complex global environment.
  • Enables informed decisions on supply chain configuration, risk mitigation, and product rollout across diverse regions and distribution channels.
  • Offers actionable pathways for developing integrated response strategies to emerging epidemiological, technological, and tariff-related challenges.

Conclusion

The bovine respiratory disease treatment sector is entering a phase defined by tailored therapies, digitized monitoring, and adaptive supply chains. Strategic collaboration and data-driven action will shape the industry’s future resilience and sustainable growth potential.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of long-acting antibiotic formulations to reduce BRD relapse rates
5.2. Development of precision antimicrobial stewardship protocols to curb BRD resistance
5.3. Adoption of novel immunomodulators enhancing bovine innate defenses against respiratory pathogens
5.4. Utilization of digital biosurveillance and AI analytics for early detection of BRD outbreaks
5.5. Advances in feed additive delivery systems targeting respiratory microbiome balance in cattle
5.6. Emergence of gene-editing techniques to enhance bovine resistance to respiratory disease challenges
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bovine Respiratory Disease Treatment Market, by Product Type
8.1. Introduction
8.2. Antibiotics
8.2.1. Beta Lactams
8.2.2. Fluoroquinolones
8.2.3. Macrolides
8.2.3.1. Tilmicosin
8.2.3.2. Tulathromycin
8.2.3.3. Tylosin
8.2.4. Tetracyclines
8.3. Vaccines
8.3.1. Inactivated
8.3.1.1. BRSV
8.3.1.2. Pasteurella
8.3.1.3. PI3
8.3.2. Live Attenuated
8.3.2.1. BRSV
8.3.2.2. Mannheimia
8.3.2.3. PI3
9. Bovine Respiratory Disease Treatment Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Intravenous
9.2.3. Subcutaneous
9.3. Intranasal
9.4. Oral
9.4.1. Feed
9.4.2. Water
10. Bovine Respiratory Disease Treatment Market, by Animal Type
10.1. Introduction
10.2. Adult Cattle
10.2.1. Beef Cattle
10.2.2. Dairy Cows
10.3. Calves
10.3.1. Beef Calves
10.3.2. Dairy Calves
10.4. Heifers
11. Bovine Respiratory Disease Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Feed Mills
11.2.1. Commercial Mills
11.2.2. Onfarm Mills
11.3. Online Pharmacies
11.3.1. Animal Health Platforms
11.3.2. General ERetail
11.4. Veterinary Clinics
11.4.1. Independent Clinics
11.4.2. Large Practices
12. Americas Bovine Respiratory Disease Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Bovine Respiratory Disease Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Bovine Respiratory Disease Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Zoetis Inc.
15.3.2. Boehringer Ingelheim International GmbH
15.3.3. Merck & Co., Inc.
15.3.4. Elanco Animal Health Incorporated
15.3.5. Ceva Santé Animale S.A.
15.3.6. Virbac S.A.
15.3.7. Phibro Animal Health Corporation
15.3.8. Vetoquinol S.A.
15.3.9. Dechra Pharmaceuticals PLC
15.3.10. Bimeda Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BOVINE RESPIRATORY DISEASE TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BOVINE RESPIRATORY DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BOVINE RESPIRATORY DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BOVINE RESPIRATORY DISEASE TREATMENT MARKET: RESEARCHAI
FIGURE 24. BOVINE RESPIRATORY DISEASE TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. BOVINE RESPIRATORY DISEASE TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. BOVINE RESPIRATORY DISEASE TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BOVINE RESPIRATORY DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY BETA LACTAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY BETA LACTAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TILMICOSIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TILMICOSIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TULATHROMYCIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TULATHROMYCIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TYLOSIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TYLOSIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TETRACYCLINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY BRSV, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY BRSV, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PASTEURELLA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PASTEURELLA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PI3, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PI3, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY BRSV, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY BRSV, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MANNHEIMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MANNHEIMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PI3, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PI3, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INTRANASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY WATER, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY WATER, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY BEEF CATTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DAIRY COWS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DAIRY COWS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY BEEF CALVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY BEEF CALVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DAIRY CALVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DAIRY CALVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY HEIFERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY HEIFERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COMMERCIAL MILLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COMMERCIAL MILLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONFARM MILLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONFARM MILLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL HEALTH PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL HEALTH PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY GENERAL ERETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY GENERAL ERETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LARGE PRACTICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LARGE PRACTICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 191. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 194. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 195. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
TABLE 196. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2025-2030 (USD MILLION)
TABLE 197. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 198. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 199. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 200. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 201. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, 2018-2024 (USD MILLION)
TABLE 202. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, 2025-2030 (USD MILLION)
TABLE 203. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 206. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 207. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 208. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 209. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 210. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 211. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2018-2024 (USD MILLION)
TABLE 212. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2025-2030 (USD MILLION)
TABLE 213. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2018-2024 (USD MILLION)
TABLE 214. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2025-2030 (USD MILLION)
TABLE 215. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2018-2024 (USD MILLION)
TABLE 218. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2025-2030 (USD MILLION)
TABLE 219. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 220. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 221. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 222. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 223. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 226. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 227. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
TABLE 228. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2025-2030 (USD MILLION)
TABLE 229. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 230. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 231. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 232. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 233. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, 2018-2024 (USD MILLION)
TABLE 234. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, 2025-2030 (USD MILLION)
TABLE 235. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 238. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 239. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 240. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 241. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 242. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 243. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2018-2024 (USD MILLION)
TABLE 244. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2025-2030 (USD MILLION)
TABLE 245. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2018-2024 (USD MILLION)
TABLE 246. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2025-2030 (USD MILLION)
TABLE 247. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2018-2024 (USD MILLION)
TABLE 250. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2025-2030 (USD MILLION)
TABLE 251. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 252. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 253. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 254. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY LIVE ATTENUATED, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ADULT CATTLE, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CALVES, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY FEED MILLS, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY MACROLIDES, 2025-2030 (USD MILLION)
TABLE 293.

Samples

Loading
LOADING...

Companies Mentioned

  • Zoetis Inc.
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Bimeda Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.27 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.27 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Bovine Respiratory Disease Treatment - Global Strategic Business Report - Product Image

Bovine Respiratory Disease Treatment - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Ceftiofur Market by Animal Type (Cattle, Poultry, Swine), Indication (Gastrointestinal Infections, Respiratory Infections, Systemic Infections), Route, Formulation, End User - Global Forecast 2025-2030 - Product Image

Ceftiofur Market by Animal Type (Cattle, Poultry, Swine), Indication (Gastrointestinal Infections, Respiratory Infections, Systemic Infections), Route, Formulation, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Animal Vaccines Market by Product (Inactivated Vaccines, Live Attenuated Vaccines, mRNA Vaccines), Animal Type (Companion Animals, Livestock Animals), Disease Type, Route of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Animal Vaccines Market by Product (Inactivated Vaccines, Live Attenuated Vaccines, mRNA Vaccines), Animal Type (Companion Animals, Livestock Animals), Disease Type, Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Bovine Treatment Systems - Global Strategic Business Report - Product Image

Bovine Treatment Systems - Global Strategic Business Report

  • Report
  • 181 Pages
  • Global
From
Ruminant Vaccines Market Size, Share & Trends Analysis Report By Animal Type, By Vaccine Type, By Indication, By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Ruminant Vaccines Market Size, Share & Trends Analysis Report By Animal Type, By Vaccine Type, By Indication, By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From

About the Bovine Respiratory Diseases Drug Market

The Bovine Respiratory Diseases Drug market is a segment of the Animal Pharmaceuticals industry that focuses on the development and sale of drugs used to treat respiratory diseases in cattle. These drugs are used to treat a variety of conditions, including pneumonia, bronchitis, and other respiratory infections. The drugs are typically administered orally or through injection, and may be used in combination with other treatments. The market is highly competitive, with a number of companies offering a variety of products. The Bovine Respiratory Diseases Drug market is driven by the increasing prevalence of respiratory diseases in cattle, as well as the need for effective treatments. Additionally, the development of new drugs and technologies has enabled the market to expand. Some of the major companies in the Bovine Respiratory Diseases Drug market include Merck Animal Health, Boehringer Ingelheim, Elanco, Zoetis, and Bayer Animal Health. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.